$-2.39 EPS Expected for GW Pharmaceuticals plc (GWPH)

November 11, 2018 - By Robert Crowder

Analysts expect GW Pharmaceuticals plc (NASDAQ:GWPH) to report $-2.39 EPS on December, 3.They anticipate $0.21 EPS change or 9.63 % from last quarter’s $-2.18 EPS. After having $-1.26 EPS previously, GW Pharmaceuticals plc’s analysts see 89.68 % EPS growth. The stock decreased 6.90% or $10.22 during the last trading session, reaching $137.87. About 773,688 shares traded or 38.84% up from the average. GW Pharmaceuticals plc (NASDAQ:GWPH) has risen 29.17% since November 11, 2017 and is uptrending. It has outperformed by 13.55% the S&P500.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Coverage

Among 5 analysts covering GW Pharma (NASDAQ:GWPH), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. GW Pharma had 6 analyst reports since June 25, 2018 according to SRatingsIntel. The firm has “Overweight” rating given on Thursday, October 11 by Morgan Stanley. The firm has “Buy” rating given on Tuesday, June 26 by Goldman Sachs. As per Tuesday, June 26, the company rating was maintained by Bank of America. On Monday, June 25 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) has “Overweight” rating given on Friday, September 7 by Morgan Stanley.

GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company has market cap of $4.46 billion. It operates through three divisions: Commercial, Sativex Research and Development, and Pipeline Research and Development. It currently has negative earnings. The firm markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis.

More notable recent GW Pharmaceuticals plc (NASDAQ:GWPH) news were published by: Nasdaq.com which released: “GW Pharmaceuticals to Report Fourth Quarter and Year-End Financial Results and Host Conference Call on 27 …” on November 06, 2018, also Finance.Yahoo.com with their article: “3 Smokin’ Hot Marijuana Stocks to Trade for the Next High” published on November 07, 2018, Benzinga.com published: “Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week” on November 09, 2018. More interesting news about GW Pharmaceuticals plc (NASDAQ:GWPH) were released by: Fool.com and their article: “Better Buy: GW Pharmaceuticals PLC vs. 22nd Century Group Inc.” published on October 21, 2018 as well as Schaeffersresearch.com‘s news article titled: “3 Weed Stocks Popping After Michigan Legalizes Pot” with publication date: November 07, 2018.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.